We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+10.25%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$339B
AUM Growth
+$32.7B
Cap. Flow
+$7.03B
Cap. Flow %
2.08%
Top 10 Hldgs %
18.14%
Holding
3,647
New
148
Increased
2,572
Reduced
501
Closed
58

Sector Composition

Rank Sector Weight
1 Technology 21.96%
2 Financials 12.71%
3 Healthcare 11.98%
4 Consumer Discretionary 10.85%
5 Industrials 8.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IPI icon
2876
Intrepid Potash
IPI
$456M
$1.09M ﹤0.01%
25,588
EGLE
2877
DELISTED
Eagle Bulk Shipping Inc.
EGLE
$1.09M ﹤0.01%
23,991
+249
+1% +$10.6K
BHB icon
2878
Bar Harbor Bankshares
BHB
$665M
$1.09M ﹤0.01%
37,689
+1,106
+3% +$32.6K
CTT
2879
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
$1.08M ﹤0.01%
124,099
+1,793
+1% +$16K
HROW icon
2880
Harrow
HROW
$1.45B
$1.08M ﹤0.01%
124,962
BGRY
2881
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
$1.08M ﹤0.01%
196,340
+3,768
+2% +$21.6K
VOR icon
2882
Vor Biopharma
VOR
$1.15B
$1.07M ﹤0.01%
4,617
+144
+3% +$41.5K
MLCO icon
2883
Melco Resorts & Entertainment
MLCO
$2.22B
$1.07M ﹤0.01%
105,007
-1,076
-1% -$11.5K
ALBO
2884
DELISTED
Albireo Pharma Inc
ALBO
$1.07M ﹤0.01%
45,772
+1,358
+3% +$36.1K
ICPT
2885
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$1.06M ﹤0.01%
65,319
-4,892
-7% -$82.5K
TARS icon
2886
Tarsus Pharmaceuticals
TARS
$2.58B
$1.06M ﹤0.01%
47,181
+415
+0.9% +$10.8K
FUTU icon
2887
Futu Holdings
FUTU
$14.7B
$1.06M ﹤0.01%
24,468
-1,070
-4% -$61.2K
PRLD icon
2888
Prelude Therapeutics
PRLD
$366M
$1.06M ﹤0.01%
85,137
+1,152
+1% +$18.7K
BLFY
2889
DELISTED
Blue Foundry Bancorp
BLFY
$1.06M ﹤0.01%
72,268
ATOM icon
2890
Atomera
ATOM
$200M
$1.06M ﹤0.01%
52,514
+1,391
+3% +$32.7K
CARE icon
2891
Carter Bankshares
CARE
$766M
$1.05M ﹤0.01%
68,510
+276
+0.4% +$4.16K
EWCZ
2892
DELISTED
European Wax Center
EWCZ
$1.05M ﹤0.01%
34,752
+9,011
+35% +$256K
IWR icon
2893
iShares Russell Mid-Cap ETF
IWR
$56B
$1.05M ﹤0.01%
12,700
+2,800
+28% +$230K
DJCO icon
2894
Daily Journal
DJCO
$809M
$1.05M ﹤0.01%
2,948
+100
+4% +$35.3K
ITIC
2895
Investors Title Co
ITIC
$546M
$1.05M ﹤0.01%
5,325
SPRO icon
2896
Spero Therapeutics
SPRO
$67.7M
$1.05M ﹤0.01%
65,547
+1,961
+3% +$31.1K
ULH icon
2897
Universal Logistics Holdings
ULH
$353M
$1.04M ﹤0.01%
55,003
-7,611
-12% -$151K
CRIS icon
2898
Curis
CRIS
$9.78M
$1.04M ﹤0.01%
545
+11
+2% +$26.2K
APYX icon
2899
Apyx Medical
APYX
$173M
$1.04M ﹤0.01%
80,775
+2,360
+3% +$33K
DFTX
2900
Definium Therapeutics
DFTX
$5.78B
$1.03M ﹤0.01%
49,959
+822
+2% +$26.2K

Similar funds

Charles Schwab's Q4 2021 Portfolio in Review

As of Q4 2021, Charles Schwab held 3,647 positions worth $339B, up 11% from $306B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Charles Schwab's Q4 2021 filing shows 148 new, 2,572 increased, 501 reduced and 58 closed positions. Its largest new stake was Kyndryl: 2,951,149 shares worth $53.4M. The largest sale was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, an estimated $421M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q4 2021 buy was Kyndryl: 2,951,149 shares worth $53.4M.
  • Charles Schwab added most to State Street SPDR Portfolio Short Term Treasury ETF in Q4 2021, an estimated $465M increase.
  • Charles Schwab's biggest Q4 2021 reduction was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, cutting an estimated $421M.
  • Charles Schwab fully exited Kansas City Southern in Q4 2021, selling an estimated $113M.
  • Charles Schwab's ten largest holdings make up 18% of its $339B portfolio in Q4 2021.
  • Charles Schwab opened 148 new positions and closed 58 in Q4 2021.
  • Charles Schwab's portfolio value rose 11% quarter-over-quarter to $339B.

Based on Charles Schwab's 13F filing for Q4 2021, filed 11 Feb 2022.